Venestatin could provide a novel therapeutic target for the treatment of RAGE-mediated inflammatory diseases, such as Alzheimer’s disease, rheumatoid arthritis, asthma, ulcerative colitis, and diabetes. The gene discussed is AGER; the disease is early-onset autosomal dominant Alzheimer disease.